<DOC>
	<DOCNO>NCT02110238</DOCNO>
	<brief_summary>The purpose study demonstrate non-inferiority three weekly intra-articular injection SUPARTZ three weekly intra-articular injection Euflexxa relief knee OA .</brief_summary>
	<brief_title>Non-Inferiority Study Comparing 3 Weekly Injections SUPARTZ® vs 3 Weekly Injections Euflexxa® Knee OA</brief_title>
	<detailed_description>The purpose study demonstrate non-inferiority three weekly intra-articular injection SUPARTZ three weekly intra-articular injection Euflexxa relief knee joint pain subject osteoarthritis ( OA ) knee measure VAS ( 0-100 mm ) Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) Pain subscale score Change Baseline ( CFB ) Weeks 3 , 6 , 12 . Safety access record adverse event , concomitant medication , physical examination , vital sign .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Clinical evidence symptomatic osteoarthritis study knee classify accord Altman criterion . Symptoms study knee least one year prior screen visit Verified OA study knee Grade 2 3 accord modification grading system KellgrenLawrence ( KL ) radiographic severity . Willingness discontinue NSAIDs ( systemic topical ) nonacetaminophen analgesic use seven day five halflives prior first injection throughout study . Inability perform 50 foot walk test . Subjects rheumatoid arthritis , joint infection , inflammatory metabolic arthritis , Lupus dermatologic disorder skin condition close proximity study knee would preclude safe intraarticular injection . Prior hyaluronic acid injection study knee within six month screen visit . Intraarticular intramuscular steroid injection within three month screen visit study participation . Oral corticosteroid within four week screen visit study participation . History surgical treatment study knee arthroscopic intervention within three month prior screen visit . Clinically apparent tense effusion study knee examination determine either positive bulge sign positive ballottement patella ( patellar tap ) . Subjects clinically diagnose symptomatic OA hip .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>knee pain</keyword>
	<keyword>Supartz</keyword>
	<keyword>Euflexxa</keyword>
	<keyword>HA</keyword>
	<keyword>hyaluronic acid</keyword>
</DOC>